A detailed history of Prime Capital Investment Advisors, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Prime Capital Investment Advisors, LLC holds 64,191 shares of NVO stock, worth $5.61 Million. This represents 0.11% of its overall portfolio holdings.

Number of Shares
64,191
Previous 73,688 12.89%
Holding current value
$5.61 Million
Previous $10.5 Million 27.33%
% of portfolio
0.11%
Previous 0.16%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 05, 2024

SELL
$119.07 - $145.42 $1.13 Million - $1.38 Million
-9,497 Reduced 12.89%
64,191 $7.64 Million
Q2 2024

Aug 08, 2024

SELL
$122.71 - $146.91 $1.4 Million - $1.68 Million
-11,423 Reduced 13.42%
73,688 $10.5 Million
Q1 2024

May 14, 2024

SELL
$102.11 - $135.92 $2.4 Million - $3.2 Million
-23,515 Reduced 21.65%
85,111 $10.9 Million
Q4 2023

Jan 24, 2024

BUY
$87.78 - $105.45 $8.19 Million - $9.84 Million
93,307 Added 609.09%
108,626 $11.2 Million
Q3 2023

Nov 09, 2023

BUY
$90.94 - $199.54 $660,770 - $1.45 Million
7,266 Added 90.23%
15,319 $1.39 Million
Q2 2023

Aug 08, 2023

BUY
$155.98 - $172.65 $616,276 - $682,140
3,951 Added 96.32%
8,053 $1.3 Million
Q1 2023

May 05, 2023

SELL
$132.34 - $159.14 $8,999 - $10,821
-68 Reduced 1.63%
4,102 $652,000
Q4 2022

Feb 08, 2023

BUY
$102.55 - $135.33 $119,470 - $157,659
1,165 Added 38.77%
4,170 $564,000
Q3 2022

Nov 08, 2022

BUY
$95.28 - $116.93 $5,145 - $6,314
54 Added 1.83%
3,005 $299,000
Q2 2022

Aug 12, 2022

SELL
$103.24 - $121.81 $13,214 - $15,591
-128 Reduced 4.16%
2,951 $329,000
Q4 2021

Feb 07, 2022

BUY
$95.88 - $117.08 $12,272 - $14,986
128 Added 4.34%
3,079 $345,000
Q3 2021

Nov 09, 2021

SELL
$84.42 - $106.62 $42,294 - $53,416
-501 Reduced 14.51%
2,951 $283,000
Q2 2021

Aug 12, 2021

SELL
$67.66 - $84.76 $4,736 - $5,933
-70 Reduced 1.99%
3,452 $289,000
Q1 2021

May 07, 2021

BUY
$67.06 - $75.82 $193,803 - $219,119
2,890 Added 457.28%
3,522 $237,000
Q4 2020

Feb 03, 2021

SELL
$63.89 - $73.8 $894 - $1,033
-14 Reduced 2.17%
632 $44,000
Q3 2020

Nov 06, 2020

SELL
$63.69 - $70.22 $3,311 - $3,651
-52 Reduced 7.45%
646 $45,000
Q2 2020

Jul 17, 2020

BUY
$58.54 - $67.94 $14,635 - $16,985
250 Added 55.8%
698 $46,000
Q1 2020

May 04, 2020

SELL
$49.46 - $64.78 $1,928 - $2,526
-39 Reduced 8.01%
448 $27,000
Q4 2019

Feb 04, 2020

SELL
$49.86 - $58.26 $2,592 - $3,029
-52 Reduced 9.65%
487 $28,000
Q3 2019

Nov 05, 2019

BUY
$47.54 - $53.43 $25,624 - $28,798
539 New
539 $28,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $197B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Prime Capital Investment Advisors, LLC Portfolio

Follow Prime Capital Investment Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Prime Capital Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Prime Capital Investment Advisors, LLC with notifications on news.